Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2008; 14(47): 7214-7219
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7214
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7214
Demographic data | |||
Number of patients | 25 | ||
Gender: Male/Female | 18/7 | ||
Age: Median (range) | 55 (40-81) | ||
TIPS indication | |||
Ascites | 20 | ||
Esophageal varices | 2 | ||
Others | 3 | ||
Child-Pugh classification | |||
A | 5 | ||
B | 14 | ||
C | 6 | ||
Biochemical markers of hepatic function | Median | IQR | Reference range |
Bilirubin (mmol/L) | 20 | 13-35 | < 17 |
Aspartate aminotransferase (U/L) | 19 | 13-34 | < 50 |
Alanine aminotransferase (U/L) | 15 | 7-27 | < 50 |
Alkaline phosphatase (U/L) | 135 | 99-185 | < 124 |
Prothrombin time (%) | 72 | 59-81 | > 70 |
Factor V (%) | 52 | 40-80 | > 75 |
Antithrombin (%) | 67 | 48-79 | > 75 |
Fibrinogen (mg/dL) | 299 | 232-408 | 180-350 |
Albumin (g/L) | 35 | 31-41 | 37-53 |
Cholinesterase (U/L) | 2049 | 1461-2800 | 5320-12 920 |
Alpha-fetoprotein (ng/mL) | 3.1 | 2.5-4.0 | < 8.1 |
Biochemical markers of renal function | |||
Urea (mmol/L) | 13 | 8-18 | 4-18 |
Creatinine (μmol/L) | 77 | 59-113 | < 97 |
Creatinine clearance (mL/min) | 80 | 38-115 | 97-160 |
Just before TIPS | Directly after TIPS | 3 mo after TIPS | ||||
Median | IQR | Median | IQR | Median | IQR | |
ADMA | ||||||
Caval vein | 0.64 | 0.58-0.72 | 0.69 | 0.61-0.78 | 0.59 | 0.53-0.74 |
Portal vein | 0.67 | 0.60-0.79 | 0.7 | 0.62-0.80 | 0.58 | 0.52-0.77 |
Hepatic vein | 0.62 | 0.59-0.71 | 0.66 | 0.57-0.84 | 0.57 | 0.52-0.74 |
SDMA | ||||||
Caval vein | 0.74 | 0.60-1.16 | 0.81 | 0.64-1.11 | 0.61a | 0.46-0.86 |
Portal vein | 0.79 | 0.62-1.13 | 0.72 | 0.64-1.06 | 0.62a | 0.46-0.89 |
Hepatic vein | 0.79 | 0.61-1.09 | 0.77 | 0.64-1.09 | 0.60a | 0.44-0.89 |
Arginine | ||||||
Caval vein | 64 | 56-85 | 76 | 68-102 | 77a | 65-104 |
Portal vein | 69 | 62-93 | 79 | 64-102 | 90a | 70-106 |
Hepatic vein | 54 | 46-75 | 67 | 59-88 | 72a | 57-101 |
Arginine/ADMA | ||||||
Caval vein | 95 | 83-132 | 117 | 89-141 | 128a | 110-175 |
Portal vein | 83 | 68-123 | 98 | 80-130 | 123a | 92-152 |
Hepatic vein | 108 | 88-138 | 114 | 88-137 | 141a | 112-185 |
NOx | Just before TIPS | Directly after TIPS | 3 mo after TIPS | |||
Median | IQR | Median | IQR | Median | IQR | |
Systemic vein | 112 | 37-243 | 107 | 33-212 | 44 | 26-103 |
Portal vein | 83 | 35-241 | 85 | 45-223 | 57 | 21-96 |
Hepatic vein | 85 | 35-304 | 86 | 32-220 | 39 | 21-76 |
- Citation: Siroen MP, Wiest R, Richir MC, Teerlink T, Rauwerda JA, Drescher FT, Zorger N, Leeuwen PAV. Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients. World J Gastroenterol 2008; 14(47): 7214-7219
- URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7214.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.7214